0R15 9213.0 1.2863% 0R1E 9139.0 0.0% 0M69 21890.0 73.8681% 0R2V 247.9 -5.3817% 0QYR 1507.0 1.4132% 0QYP 453.9399 0.8755% 0RUK None None% 0RYA 1564.0 -0.0639% 0RIH 191.65 0.0% 0RIH 194.2 1.3306% 0R1O 230.5 9921.7391% 0R1O None None% 0QFP 10743.4102 113.1629% 0M2Z 266.1322 0.4272% 0VSO 33.33 -6.3896% 0R1I None None% 0QZI 625.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 177.8 -2.254%
Last update at 2024-12-12T16:37:00Z
This Oxford Nanopore Technologies Insider Increased Their Holding By 56% Last Year
Tue 28 Nov 23, 08:25 AMOxford Nanopore Technologies First Half 2023 Earnings: Revenues Beat Expectations, EPS Lags
Fri 08 Sep 23, 05:06 AM3 Things About Pacific Biosciences of California That Smart Investors Know
Tue 12 Apr 22, 12:25 PMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | -83.41100M | -166.00400M | -73.15300M | -80.48400M | -62.02500M |
Minority interest | - | - | - | - | - |
Net income | -91.02500M | -167.61300M | -61.24400M | -72.21600M | -53.11900M |
Selling general administrative | 157.45M | 161.75M | 71.39M | 66.06M | 41.09M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 123.81M | 73.19M | 46.88M | 25.62M | 16.02M |
Reconciled depreciation | 31.87M | 24.69M | 17.34M | 14.85M | 6.36M |
Ebit | -98.47900M | -164.53300M | -73.06000M | -80.89300M | -61.60200M |
Ebitda | -60.90500M | -139.17800M | -55.63400M | -65.62500M | -55.24600M |
Depreciation and amortization | 37.57M | 25.36M | 17.43M | 15.27M | 6.36M |
Non operating income net other | - | - | - | - | - |
Operating income | -98.47900M | -164.53300M | -73.06000M | -80.89300M | -62.17600M |
Other operating expenses | 297.08M | 298.19M | 186.92M | 132.95M | 94.70M |
Interest expense | 1.63M | 0.91M | 0.75M | 0.61M | 0.42M |
Tax provision | 7.61M | 1.61M | -11.90900M | -8.26800M | -8.90600M |
Interest income | 5.94M | 0.22M | 0.09M | 0.52M | 0.57M |
Net interest income | 4.31M | -0.68400M | -0.65600M | -0.09600M | 0.15M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 7.61M | 1.61M | -11.90900M | -8.26800M | -8.90600M |
Total revenue | 198.60M | 133.66M | 113.86M | 52.06M | 32.52M |
Total operating expenses | 222.29M | 237.73M | 119.94M | 106.51M | 78.19M |
Cost of revenue | 74.79M | 60.47M | 66.98M | 26.44M | 16.51M |
Total other income expense net | 15.07M | -1.47100M | -0.09300M | 0.41M | 0.15M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -91.02500M | -167.61300M | -61.24400M | -72.21600M | -53.11900M |
Net income applicable to common shares | -91.02500M | -167.61300M | -61.24400M | -72.21600M | -53.11900M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Total assets | 823.89M | 841.87M | 281.21M | 164.74M | 175.19M |
Intangible assets | 30.04M | 23.00M | 22.87M | 16.52M | 6.41M |
Earning assets | - | - | - | - | - |
Other current assets | 2.06M | 69.07M | 86.66M | 71.39M | 30.39M |
Total liab | 130.33M | 137.89M | 95.28M | 55.21M | 32.30M |
Total stockholder equity | 693.56M | 703.98M | 185.93M | 109.53M | 142.89M |